Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study

Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study

Abstract Background There is no currently available treatment for peritoneal metastasis of gastric cancer. This phase II study aimed to evaluate the efficacy and safety of neoadjuvant systemic chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery (CRS...

Full description

Bibliographic Details
Main Authors: Pengfei Yu, Zeyao Ye, Gaiguo Dai, Yanqiang Zhang, Ling Huang, Yian Du, Xiangdong Cheng
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Cancer
Subjects:
Gastric neoplasm
Peritoneal metastasis
HIPEC
Chemotherapy
Surgery
Prognosis
Online Access:http://link.springer.com/article/10.1186/s12885-020-07601-x

Internet

http://link.springer.com/article/10.1186/s12885-020-07601-x

Similar Items